Organogenesis | SCHEDULE 13G/A: Others
Organogenesis | SCHEDULE 13D/A: Others
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Director Ades Alan A.
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Director Ades Alan A.
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Director Ades Alan A.
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Director Ades Alan A.
Organogenesis | 3: Initial statement of beneficial ownership of securities-10% Owner Ades Josette
Organogenesis | SCHEDULE 13D/A: Others
Organogenesis | 424B3: Prospectus
Organogenesis | EFFECT: Others
Organogenesis | CORRESP: CORRESP
Organogenesis | UPLOAD: Others
Organogenesis | S-3: Registration statement for specified transactions by certain issuers
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Gillheeney Gary S.
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Gillheeney Gary S.
Organogenesis | 4: Statement of changes in beneficial ownership of securities-Officer Gillheeney Gary S.
Organogenesis | 144: Notice of proposed sale of securities pursuant to Rule 144
Organogenesis | 4: Statement of changes in beneficial ownership of securities-10% Owner GN 2016 Family Trust u/a/d August 12, 2016
Organogenesis | 4: Statement of changes in beneficial ownership of securities-10% Owner GN 2016 Family Trust u/a/d August 12, 2016
Organogenesis | 8-K: Current report